SCHEMBL3723906

SCHEMBL3723906

COc1ccc(Nc2nc(CN)cc(-c3ccc4c(c3)OCO4)n2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 2/20 0.51
MAPT P10636 5/20 0.49
DYRK1A Q13627 3/20 0.49
ALDH1A1 P00352 3/20 0.49
CLK1 P49759 2/20 0.49
CLK4 Q9HAZ1 2/20 0.49
DYRK1B Q9Y463 2/20 0.49
LMNA P02545 2/20 0.49
HPGD P15428 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
CLK2 P49760 1/20 0.49
KDM4E B2RXH2 1/20 0.49
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
GAA P10253 3/20 0.47
TSHR P16473 2/20 0.47
MEN1 O00255 4/20 0.45
KMT2A Q03164 4/20 0.45
ADORA3 P0DMS8 3/20 0.45
ADORA1 P30542 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3717907 0.86 CLK4 (0.52) MAPTDYRK1AALDH1A1CLK1CLK4
SCHEMBL3725579 0.86 DYRK1A (0.65) PTGS2MAPTDYRK1AALDH1A1CLK1
SCHEMBL3724659 0.79 DYRK1A (0.51) PTGS2MAPTDYRK1ACLK1CLK4
SCHEMBL3720901 0.78 HPGD (0.47) MAPTDYRK1AALDH1A1CLK1CLK4
SCHEMBL3723229 0.76 ADORA1 (0.48) DYRK1AALDH1A1CLK1CLK4DYRK1B
SCHEMBL3721197 0.75 ADORA1 (0.51) MAPTDYRK1ACLK1CLK4DYRK1B
SCHEMBL22100264 0.74 ALDH1A1 (0.61) PTGS2MAPTDYRK1AALDH1A1LMNA
SCHEMBL14458159 0.74 PTGS2 (0.87) PTGS2MAPTALDH1A1LMNASMN1; SMN2
SCHEMBL3721028 0.73 ADORA1 (0.48) MAPTALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL17545085 0.73 MAPT (0.49) PTGS2MAPTALDH1A1LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010141805-A1 HETEROCYCLIC AMIDES AS MODULATORS OF TRPA1 JANSSEN PHARMACEUTICA NV (BE) 2010-12-09 WO disclosed